Prognosis markers for metastatic renal cell carcinoma: quantitative proteomics approach

By Dihazi Hassan  

Expert Review of Proteomics, Vol. 10, Iss. 1, 2013-02 ,pp. : 21-24

Informa Healthcare

Access to resources Recommend Favorite

Bevacizumab for metastatic renal cell carcinoma: a monoclonal antibody in a sea of small molecules

By Pal Sumanta Kumar   Figlin Robert A  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 11, 2010-11 ,pp. : 1517-1520

Informa Healthcare

Access to resources Recommend Favorite

SLP-2 overexpression is associated with tumour distant metastasis and poor prognosis in pulmonary squamous cell carcinoma

By Chang Dong   Ma Kai   Gong Min   Cui Yong   Liu Zhi-hua   Zhou Xiao-ge   Zhou Chuan-nong   Wang Tian-you  

Biomarkers, Vol. 15, Iss. 2, 2010-03 ,pp. : 104-110

Informa Healthcare

Access to resources Recommend Favorite

Comparison of protein expression patterns between hepatocellular carcinoma cell lines and a hepatoblastoma cell line

By Pang Ronald  

Clinical Proteomics, Vol. 1, Iss. 3-4, 2004-09 ,pp. : 313-331

Humana Press, Inc

Access to resources Recommend Favorite

Interleukin-21: updated review of Phase I and II clinical trials in metastatic renal cell carcinoma, metastatic melanoma and relapsed/refractory indolent non-Hodgkin's lymphoma

By Hashmi Mehmood H   Van Veldhuizen Peter J  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 5, 2010-05 ,pp. : 807-817

Informa Healthcare

Access to resources Recommend Favorite